We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.08B
AUM Growth
-$5.49M
Cap. Flow
-$122M
Cap. Flow %
-5.86%
Top 10 Hldgs %
17.85%
Holding
3,178
New
224
Increased
394
Reduced
834
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 14.29%
2 Financials 12.63%
3 Industrials 10.03%
4 Healthcare 9.5%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOOM icon
1976
DMC Global
BOOM
$155M
$49K ﹤0.01%
1,092
DHIL
1977
DELISTED
Diamond Hill
DHIL
$49K ﹤0.01%
250
DXPE icon
1978
DXP Enterprises
DXPE
$2.99B
$49K ﹤0.01%
1,272
MLAB icon
1979
Mesa Laboratories
MLAB
$625M
$49K ﹤0.01%
233
ZS icon
1980
Zscaler
ZS
$29.9B
$49K ﹤0.01%
+1,357
New +$41.4K
BVH
1981
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$49K ﹤0.01%
+1,086
New +$50.2K
GHL
1982
DELISTED
Greenhill & Co., Inc.
GHL
$49K ﹤0.01%
1,714
-546
-24% -$13.3K
CIR
1983
DELISTED
CIRCOR International, Inc
CIR
$49K ﹤0.01%
1,323
ADMS
1984
DELISTED
Adamas Pharmaceuticals
ADMS
$49K ﹤0.01%
1,883
+582
+45% +$16.1K
CISN
1985
DELISTED
Cision Ltd. Ordinary Share
CISN
$49K ﹤0.01%
+3,270
New +$45.9K
LION
1986
DELISTED
Fidelity Southern Corporation
LION
$49K ﹤0.01%
1,909
ACLS icon
1987
Axcelis
ACLS
$4.36B
$48K ﹤0.01%
2,416
BCRX icon
1988
BioCryst Pharmaceuticals
BCRX
$2.43B
$48K ﹤0.01%
8,297
CBIO
1989
Crescent Biopharma
CBIO
$623M
$48K ﹤0.01%
+30
New +$51.6K
GRC icon
1990
Gorman-Rupp
GRC
$2.13B
$48K ﹤0.01%
1,373
IEMG icon
1991
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
$48K ﹤0.01%
923
+12
+1% +$673
IGLB icon
1992
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
$48K ﹤0.01%
845
OFG icon
1993
OFG Bancorp
OFG
$2.26B
$48K ﹤0.01%
3,440
PARR icon
1994
Par Pacific Holdings
PARR
$4.1B
$48K ﹤0.01%
2,790
TCX icon
1995
Tucows
TCX
$134M
$48K ﹤0.01%
790
HK
1996
DELISTED
Halcon Resources Corporation
HK
$48K ﹤0.01%
11,000
ABR icon
1997
Arbor Realty Trust
ABR
$965M
$47K ﹤0.01%
+4,489
New +$41.7K
AGX icon
1998
Argan
AGX
$7.9B
$47K ﹤0.01%
1,155
AMPH icon
1999
Amphastar Pharmaceuticals
AMPH
$871M
$47K ﹤0.01%
3,073
CHRS icon
2000
Coherus Oncology
CHRS
$178M
$47K ﹤0.01%
3,367

Similar funds

Ameritas Investment Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Ameritas Investment Partners held 3,178 positions worth $2.08B, down 0.26% from $2.08B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $122M in Q2 2018, closing 193 positions and reducing 834 holdings. Its most notable exit was Orbital ATK, Inc., an estimated $2.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Wyndham Hotels & Resorts worth $1.75M.

  • Ameritas Investment Partners's largest Q2 2018 buy was Wyndham Hotels & Resorts: 29,700 shares worth $1.75M.
  • Ameritas Investment Partners added most to Vanguard S&P 500 ETF in Q2 2018, an estimated $5.21M increase.
  • Ameritas Investment Partners's biggest Q2 2018 reduction was iShares S&P 500 Value ETF, cutting an estimated $6.02M.
  • Ameritas Investment Partners fully exited Orbital ATK, Inc. in Q2 2018, selling an estimated $2.29M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q2 2018.
  • Ameritas Investment Partners opened 224 new positions and closed 193 in Q2 2018.
  • Ameritas Investment Partners's portfolio value fell 0.26% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.